Investigation of the anti-tumor mechanism of tirabrutinib, a highly selective Bruton’s tyrosine kinase inhibitor, by phosphoproteomics and transcriptomicsRyohei Kozaki, Takao Yoshida|PLoS ONE|2023Cited by 15